The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab monotherapy for melanoma or non-small cell lung cancer in India: Results of the phase IV keynote-593 study.
 
Sewanti Limaye
Consulting or Advisory Role - Columbia University; Harvard Medical School; Medical Oncology Dana Farber Cancer Institute
Other Relationship - IMPACTIndiaInternationalMTB; Iylon
 
Sameer Rastogi
No Relationships to Disclose
 
Pratap Das
No Relationships to Disclose
 
Dr Chetan Deshmukh
No Relationships to Disclose
 
Sadashivudu Gundeti
No Relationships to Disclose
 
Imran Shaikh
No Relationships to Disclose
 
Priya Tiwari
No Relationships to Disclose
 
Richu Sharma
No Relationships to Disclose
 
Sushmita Rath
No Relationships to Disclose
 
Kevin Lawlor
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Mizuho Fukunaga-Kalabis
Employment - MSD
Stock and Other Ownership Interests - MSD
 
Clemens Krepler
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jyoti Bajpai
Employment - Apollo Hospitals Navi Mumbai
Research Funding - Lilly (Inst); Novartis (Inst); Paxman Scalp Coolers-Access device (Inst); Roche (Inst); Samsung Bioepis (Inst); Sun Pharma (Inst)
Other Relationship - Alkem Laboratories; Dr. Reddy's Laboratories Ltd; Eisai; EMCURE PHARMACEUTICALS LIMITED; Intas; Merck Specialties Private Limited; Novartis
 
Hari Goyal
No Relationships to Disclose